IL166308A0 - Polymorphic forms of nateglinide - Google Patents

Polymorphic forms of nateglinide

Info

Publication number
IL166308A0
IL166308A0 IL16630803A IL16630803A IL166308A0 IL 166308 A0 IL166308 A0 IL 166308A0 IL 16630803 A IL16630803 A IL 16630803A IL 16630803 A IL16630803 A IL 16630803A IL 166308 A0 IL166308 A0 IL 166308A0
Authority
IL
Israel
Prior art keywords
nateglinide
polymorphic forms
polymorphic
forms
Prior art date
Application number
IL16630803A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/614,266 external-priority patent/US6861553B2/en
Application filed filed Critical
Publication of IL166308A0 publication Critical patent/IL166308A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16630803A 2002-07-18 2003-07-18 Polymorphic forms of nateglinide IL166308A0 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US39690402P 2002-07-18 2002-07-18
US41362202P 2002-09-25 2002-09-25
US41419902P 2002-09-26 2002-09-26
US42375002P 2002-11-05 2002-11-05
US43209302P 2002-12-10 2002-12-10
US43296202P 2002-12-12 2002-12-12
US44210903P 2003-01-23 2003-01-23
US44979103P 2003-02-24 2003-02-24
US47901603P 2003-06-16 2003-06-16
US10/614,266 US6861553B2 (en) 2002-07-03 2003-07-03 Process for preparing nateglinide and intermediates thereof
PCT/US2003/022375 WO2004009532A1 (en) 2002-07-18 2003-07-18 Polymorphic forms of nateglinide

Publications (1)

Publication Number Publication Date
IL166308A0 true IL166308A0 (en) 2006-01-15

Family

ID=30773824

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16630803A IL166308A0 (en) 2002-07-18 2003-07-18 Polymorphic forms of nateglinide

Country Status (6)

Country Link
EP (1) EP1467964A1 (en)
JP (1) JP2006511614A (en)
AU (1) AU2003253971A1 (en)
CA (1) CA2492644A1 (en)
IL (1) IL166308A0 (en)
WO (1) WO2004009532A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534913B2 (en) * 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
HU227073B1 (en) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Process for the preparation of chirally pure n-(trans-4-isopropyl-cyclohexylcarbonyl)-d-phenyl-alanine (nateglinide) and it's crystalline forms and the cristalline form g
JP2007528858A (en) * 2004-05-07 2007-10-18 テバ ファーマシューティカル インダストリーズ リミティド Polymorphic form of nateglinide
JP2009516655A (en) * 2005-11-22 2009-04-23 テバ ファーマシューティカル インダストリーズ リミティド Cinacalcet hydrochloride crystalline form (Form) and methods for their preparation
MX2021001169A (en) 2013-11-15 2023-02-10 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
CN109369443A (en) * 2018-11-05 2019-02-22 扬子江药业集团江苏海慈生物药业有限公司 A kind of preparation method of new Nateglinide H crystal form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (en) * 1985-03-27 1988-03-08 Ajinomoto Co Inc Blood sugar lowering agent
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
MXPA03003484A (en) * 2000-10-18 2003-07-14 Ajinomoto Kk Process for producing nateglinide crystal.
JP4225057B2 (en) * 2000-10-24 2009-02-18 味の素株式会社 Method for producing nateglinide type B crystal
WO2003022251A1 (en) * 2001-09-12 2003-03-20 Alembic Limited Novel stable crystal form of n-trans-4-isopropylcyclohexyl carbonyl)-d-phenylalanine and process of preparation
EP2264004A1 (en) * 2002-04-15 2010-12-22 Ajinomoto Co., Inc. New nateglinide crystals

Also Published As

Publication number Publication date
EP1467964A1 (en) 2004-10-20
AU2003253971A1 (en) 2004-02-09
JP2006511614A (en) 2006-04-06
WO2004009532A1 (en) 2004-01-29
CA2492644A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
IL209965A0 (en) Modafinil polymorphic forms
HK1093483A1 (en) Polymorphic form of n-
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
GB0325192D0 (en) Method of use
PT1610784T (en) Forms of 5-azacytidine
AU2003236991A8 (en) Representations of processes
HK1094190A1 (en) a polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
EP1577280A4 (en) Method of deuterization
IL176953A0 (en) Polymorphic forms of nateglinide
EP1628664A4 (en) Polymorphic forms of naltrexone
GB2407140B (en) Mounting of tubes
EP1488046A4 (en) Method of construction
IL166308A0 (en) Polymorphic forms of nateglinide
GB0206415D0 (en) Deracemisation of amines
GB2393207B (en) Means of assembly
PL356853A1 (en) Application of bacteriphages
SI1537210T1 (en) Decoy-oligonucleotide-inhbition of cd40-expression
TW562191U (en) Fastening structure of peripheral apparatus
PL351938A1 (en) Method of obtaining fructisiltransferase
PL360806A1 (en) Design of carrying unit
TW587476U (en) Improved structure of spinning-top
TW567775U (en) Structure of hairtie
GB0218917D0 (en) Method of increasing visibility
ZA200407527B (en) Method of facilitating employment
EP1511485A4 (en) Novel uses of dl-thp